160 related articles for article (PubMed ID: 34854309)
1. Immunotherapy for cancer: effects of iron oxide nanoparticles on polarization of tumor-associated macrophages.
Nascimento CS; Alves ÉAR; de Melo CP; Corrêa-Oliveira R; Calzavara-Silva CE
Nanomedicine (Lond); 2021 Dec; 16(29):2633-2650. PubMed ID: 34854309
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effect of Repolarization of M2 to M1 Macrophages Induced by Iron Oxide Nanoparticles Combined with Lactate Oxidase.
Liao ZX; Ou DL; Hsieh MJ; Hsieh CC
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948143
[TBL] [Abstract][Full Text] [Related]
3. The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.
Mulens-Arias V; Rojas JM; Barber DF
Front Immunol; 2021; 12():693709. PubMed ID: 34177955
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of tumor-associated macrophages by polyaniline-coated iron oxide nanoparticles applied to treatment of breast cancer.
Nascimento C; Castro F; Domingues M; Lage A; Alves É; de Oliveira R; de Melo C; Eduardo Calzavara-Silva C; Sarmento B
Int J Pharm; 2023 Apr; 636():122866. PubMed ID: 36934882
[TBL] [Abstract][Full Text] [Related]
5. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
6. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapeutic effect of carboxymethylated β-d-glucan coupled with iron oxide nanoparticles via reprogramming tumor-associated macrophages.
Su Y; Yang F; Wang M; Cheung PCK
Int J Biol Macromol; 2023 Feb; 228():692-705. PubMed ID: 36566807
[TBL] [Abstract][Full Text] [Related]
8. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
Ramesh A; Malik V; Brouillard A; Kulkarni A
J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
[TBL] [Abstract][Full Text] [Related]
9. [Research progress on the effect of iron oxide nanoparticles in macrophage polarization].
Zhang H; Zhang X; Feng Y; Du C; Wang Y; Guo X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Apr; 40(2):384-391. PubMed ID: 37139773
[TBL] [Abstract][Full Text] [Related]
10. Mushroom Carboxymethylated β-d-Glucan Functions as a Macrophage-Targeting Carrier for Iron Oxide Nanoparticles and an Inducer of Proinflammatory Macrophage Polarization for Immunotherapy.
Su Y; Yang F; Chen L; Cheung PCK
J Agric Food Chem; 2022 Jun; 70(23):7110-7121. PubMed ID: 35652418
[TBL] [Abstract][Full Text] [Related]
11. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
[TBL] [Abstract][Full Text] [Related]
12. Advances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy.
Kapitanova KS; Naumenko VA; Garanina AS; Melnikov PA; Abakumov MA; Alieva IB
Biochemistry (Mosc); 2019 Jul; 84(7):729-745. PubMed ID: 31509725
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy.
Wu X; Cheng Y; Zheng R; Xu K; Yan J; Song P; Wang Y; Rauf A; Pan Y; Zhang H
ACS Appl Mater Interfaces; 2021 May; 13(17):19825-19835. PubMed ID: 33881837
[TBL] [Abstract][Full Text] [Related]
14. Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages.
Zhang W; Cao S; Liang S; Tan CH; Luo B; Xu X; Saw PE
Front Bioeng Biotechnol; 2020; 8():537. PubMed ID: 32548111
[TBL] [Abstract][Full Text] [Related]
15. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract][Full Text] [Related]
16. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
Shi L; Gu H
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
[TBL] [Abstract][Full Text] [Related]
17. Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy.
Lin X; Fang Y; Jin X; Zhang M; Shi K
ACS Appl Bio Mater; 2021 Aug; 4(8):5871-5896. PubMed ID: 35006894
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD206 antibody-conjugated Fe
Zhou Y; Que KT; Tang HM; Zhang P; Fu QM; Liu ZJ
Oncol Lett; 2020 Dec; 20(6):298. PubMed ID: 33101492
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia.
Dias AMM; Courteau A; Bellaye PS; Kohli E; Oudot A; Doulain PE; Petitot C; Walker PM; Decréau R; Collin B
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365207
[TBL] [Abstract][Full Text] [Related]
20. Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors.
Dacoba TG; Anfray C; Mainini F; Allavena P; Alonso MJ; Torres Andón F; Crecente-Campo J
Front Immunol; 2020; 11():1412. PubMed ID: 32733469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
